EUVIMEDEUVIMED entdecken
Open Access

Peptide Tag-nology for Preparation of Site-Specific Antibody–Drug Conjugates

Alina Ringaci, Mark W Grinstaff iD

Bioconjugate Chemistry · 2026

DOI: 10.1021/acs.bioconjchem.6c00154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2026. Verfasst von Alina Ringaci und 1 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Chemistry and Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States. Hauptthemen laut MEDLINE: Immunoconjugates, Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, Pharmaceutical Research and Manufacturers of America Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibody–drug conjugates (ADC) are a rapidly growing therapeutic class that leverages the specificity of antibodies to deliver cytotoxic payloads to cells. While ADCs have demonstrated significant clinical success in cancer treatment, substantial challenges remain with regard to stability, low drug–antibody ratios, and heterogeneity that negatively impact pharmacokinetics, efficacy, and safety profiles. Bioconjugation and, in particular, peptide tag-nologies are key to overcoming these challenges and enabling future designs with diverse types of antibody formats, multiple payloads, and high drug loadings. This Viewpoint explores novel, facile peptide-based conjugation strategies to synthesize homogeneous and site-specific ADCs, describes the underlying conjugation reactions, and highlights the advantages of these technologies in comparison to classically used approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesPeptidesAnimalsHumans

Substanzen

ImmunoconjugatesPeptides

Autor:innen und Institutionen

  • Departments of Chemistry and Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States.

ORCID-Profile: Mark W Grinstaff

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • Pharmaceutical Research and Manufacturers of America Foundation

Zitieren

APA

Ringaci, A., & Grinstaff, M. W. (2026). Peptide Tag-nology for Preparation of Site-Specific Antibody–Drug Conjugates. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.6c00154

Vancouver

Ringaci A, Grinstaff MW. Peptide Tag-nology for Preparation of Site-Specific Antibody–Drug Conjugates. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.6c00154

BibTeX
@article{Ringaci2026,
  author = {Ringaci, Alina and Grinstaff, Mark W},
  title = {Peptide Tag-nology for Preparation of Site-Specific Antibody–Drug Conjugates},
  journal = {Bioconjugate Chemistry},
  year = {2026},
  doi = {10.1021/acs.bioconjchem.6c00154}
}
Kostenlos starten →